153 related articles for article (PubMed ID: 33442680)
1. Extracellular vimentin as a target against SARS-CoV-2 host cell invasion.
Suprewicz Ł; Swoger M; Gupta S; Piktel E; Byfield FJ; Iwamoto DV; Germann D; Reszeć J; Marcińczyk N; Carroll RJ; Lenart M; Pyre K; Janmey P; Schwarz JM; Bucki R; Patteson A
bioRxiv; 2021 Mar; ():. PubMed ID: 33442680
[TBL] [Abstract][Full Text] [Related]
2. Extracellular Vimentin as a Target Against SARS-CoV-2 Host Cell Invasion.
Suprewicz Ł; Swoger M; Gupta S; Piktel E; Byfield FJ; Iwamoto DV; Germann D; Reszeć J; Marcińczyk N; Carroll RJ; Janmey PA; Schwarz JM; Bucki R; Patteson AE
Small; 2022 Feb; 18(6):e2105640. PubMed ID: 34866333
[TBL] [Abstract][Full Text] [Related]
3. Vimentin is an important ACE2 co-receptor for SARS-CoV-2 in epithelial cells.
Arrindell J; Abou Atmeh P; Jayet L; Sereme Y; Mege JL; Desnues B
iScience; 2022 Nov; 25(11):105463. PubMed ID: 36338433
[TBL] [Abstract][Full Text] [Related]
4. In silico investigation of critical binding pattern in SARS-CoV-2 spike protein with angiotensin-converting enzyme 2.
Jafary F; Jafari S; Ganjalikhany MR
Sci Rep; 2021 Mar; 11(1):6927. PubMed ID: 33767306
[TBL] [Abstract][Full Text] [Related]
5. Competitive SARS-CoV-2 Serology Reveals Most Antibodies Targeting the Spike Receptor-Binding Domain Compete for ACE2 Binding.
Byrnes JR; Zhou XX; Lui I; Elledge SK; Glasgow JE; Lim SA; Loudermilk RP; Chiu CY; Wang TT; Wilson MR; Leung KK; Wells JA
mSphere; 2020 Sep; 5(5):. PubMed ID: 32938700
[TBL] [Abstract][Full Text] [Related]
6. Stapled Peptides Based on Human Angiotensin-Converting Enzyme 2 (ACE2) Potently Inhibit SARS-CoV-2 Infection
Curreli F; Victor SMB; Ahmed S; Drelich A; Tong X; Tseng CK; Hillyer CD; Debnath AK
mBio; 2020 Dec; 11(6):. PubMed ID: 33310780
[TBL] [Abstract][Full Text] [Related]
7. Development of cell-based pseudovirus entry assay to identify potential viral entry inhibitors and neutralizing antibodies against SARS-CoV-2.
Hu J; Gao Q; He C; Huang A; Tang N; Wang K
Genes Dis; 2020 Dec; 7(4):551-557. PubMed ID: 32837985
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of SARS-CoV-2 pseudovirus invasion by ACE2 protecting and Spike neutralizing peptides: An alternative approach to COVID19 prevention and therapy.
Chen J; Li S; Lei Z; Tang Q; Mo L; Zhao X; Xie F; Zi D; Tan J
Int J Biol Sci; 2021; 17(11):2957-2969. PubMed ID: 34345219
[TBL] [Abstract][Full Text] [Related]
9. Investigation of Interaction between the Spike Protein of SARS-CoV-2 and ACE2-Expressing Cells Using an In Vitro Cell Capturing System.
Shang Y; Chen F; Li S; Song L; Gao Y; Yu X; Zheng J
Biol Proced Online; 2021 Aug; 23(1):16. PubMed ID: 34433426
[TBL] [Abstract][Full Text] [Related]
10. A Novel Therapeutic Peptide Blocks SARS-CoV-2 Spike Protein Binding with Host Cell ACE2 Receptor.
Rajpoot S; Ohishi T; Kumar A; Pan Q; Banerjee S; Zhang KYJ; Baig MS
Drugs R D; 2021 Sep; 21(3):273-283. PubMed ID: 34324175
[TBL] [Abstract][Full Text] [Related]
11. CD147-spike protein is a novel route for SARS-CoV-2 infection to host cells.
Wang K; Chen W; Zhang Z; Deng Y; Lian JQ; Du P; Wei D; Zhang Y; Sun XX; Gong L; Yang X; He L; Zhang L; Yang Z; Geng JJ; Chen R; Zhang H; Wang B; Zhu YM; Nan G; Jiang JL; Li L; Wu J; Lin P; Huang W; Xie L; Zheng ZH; Zhang K; Miao JL; Cui HY; Huang M; Zhang J; Fu L; Yang XM; Zhao Z; Sun S; Gu H; Wang Z; Wang CF; Lu Y; Liu YY; Wang QY; Bian H; Zhu P; Chen ZN
Signal Transduct Target Ther; 2020 Dec; 5(1):283. PubMed ID: 33277466
[TBL] [Abstract][Full Text] [Related]
12. Epstein-Barr Virus Lytic Replication Induces ACE2 Expression and Enhances SARS-CoV-2 Pseudotyped Virus Entry in Epithelial Cells.
Verma D; Church TM; Swaminathan S
J Virol; 2021 Jun; 95(13):e0019221. PubMed ID: 33853968
[TBL] [Abstract][Full Text] [Related]
13. Deletion of ER-retention motif on SARS-CoV-2 spike protein reduces cell hybrid during cell-cell fusion.
Wang X; Chen CH; Badeti S; Cho JH; Naghizadeh A; Wang Z; Liu D
Cell Biosci; 2021 Jun; 11(1):114. PubMed ID: 34162440
[TBL] [Abstract][Full Text] [Related]
14. The expression of hACE2 receptor protein and its involvement in SARS-CoV-2 entry, pathogenesis, and its application as potential therapeutic target.
Al-Zaidan L; Mestiri S; Raza A; Merhi M; Inchakalody VP; Fernandes Q; Taib N; Uddin S; Dermime S
Tumour Biol; 2021; 43(1):177-196. PubMed ID: 34420993
[TBL] [Abstract][Full Text] [Related]
15. Screening of inhibitors against SARS-CoV-2 spike protein and their capability to block the viral entry mechanism: A viroinformatics study.
Farouk AE; Baig MH; Khan MI; Park T; Alotaibi SS; Dong JJ
Saudi J Biol Sci; 2021 Jun; 28(6):3262-3269. PubMed ID: 33654454
[TBL] [Abstract][Full Text] [Related]
16. Comparison of Severe Acute Respiratory Syndrome Coronavirus 2 Spike Protein Binding to ACE2 Receptors from Human, Pets, Farm Animals, and Putative Intermediate Hosts.
Zhai X; Sun J; Yan Z; Zhang J; Zhao J; Zhao Z; Gao Q; He WT; Veit M; Su S
J Virol; 2020 Jul; 94(15):. PubMed ID: 32404529
[TBL] [Abstract][Full Text] [Related]
17. Isolation of a human monoclonal antibody specific for the receptor binding domain of SARS-CoV-2 using a competitive phage biopanning strategy.
Zeng X; Li L; Lin J; Li X; Liu B; Kong Y; Zeng S; Du J; Xiao H; Zhang T; Zhang S; Liu J
Antib Ther; 2020 Apr; 3(2):95-100. PubMed ID: 33912790
[TBL] [Abstract][Full Text] [Related]
18. Broad and Differential Animal Angiotensin-Converting Enzyme 2 Receptor Usage by SARS-CoV-2.
Zhao X; Chen D; Szabla R; Zheng M; Li G; Du P; Zheng S; Li X; Song C; Li R; Guo JT; Junop M; Zeng H; Lin H
J Virol; 2020 Aug; 94(18):. PubMed ID: 32661139
[TBL] [Abstract][Full Text] [Related]
19. Molecular dynamic simulation analysis of SARS-CoV-2 spike mutations and evaluation of ACE2 from pets and wild animals for infection risk.
Chen P; Wang J; Xu X; Li Y; Zhu Y; Li X; Li M; Hao P
Comput Biol Chem; 2022 Feb; 96():107613. PubMed ID: 34896769
[TBL] [Abstract][Full Text] [Related]
20. Deletion of ER-retention Motif on SARS-CoV-2 Spike Protein Reduces Cell Hybrid During Cell-cell Fusion.
Chen CH; Badeti S; Cho JH; Naghizadeh A; Wang X; Liu D
Res Sq; 2021 Apr; ():. PubMed ID: 33851149
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]